ChemoCentryx, Inc. — Revenue by Fiscal Year
6 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/037aa1df-1cc4-4c05-9ba1-7c4d8afb88e5/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2021 | $32.2M | 2021-01-01 – 2021-12-31 | evidence 0000950170-22-002561 |
| FY 2020 | $64.9M | 2020-01-01 – 2020-12-31 | evidence 0001564590-21-009883 |
| FY 2019 | $36.1M | 2019-01-01 – 2019-12-31 | evidence 0001564590-20-009787 |
| FY 2018 | $42.9M | 2018-01-01 – 2018-12-31 | evidence 0001193125-19-070954 |
| FY 2017 | $82.5M | 2017-01-01 – 2017-12-31 | evidence 0001193125-19-070954 |
| FY 2016 | $11.9M | 2016-01-01 – 2016-12-31 | evidence 0001193125-19-070954 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
ChemoCentryx, Inc. — all facts · Net Income · Operating Income